“I Know How to Dismantle Regulatory Capture”: Robert F. Kennedy Jr.’s Battle Plan

A Convergence of Power and Policy

“All of these companies are now running the regulatory agencies, and they’re all ultimately owned by three big companies which all own each other. It’s this one giant company, and I know how to dismantle that.”
— Robert F. Kennedy Jr.

In a brief but revealing video clip, Robert F. Kennedy Jr. (RFK Jr.) spells out the underlying reality of contemporary governance: the entanglement of powerful industries with the very government agencies meant to regulate them. He calls this “Regulatory Capture”—the phenomenon wherein an industry effectively takes control of its own watchdog.

RFK Jr. underscores his unique vantage point: 40 years spent suing federal agencies like the Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and even the Federal Communications Commission (FCC). During this long legal saga, Kennedy claims to have acquired a “PhD in Regulatory Capture.” He knows the individuals involved, the perverse incentives entrenched in these bureaucracies, and the steps needed to excise the conflicts of interest that corrode public trust.

But why does this matter to the average citizen? Why should you or I care if the CDC or the FCC are “captured” by industry? In short, because regulatory capture shapes everything from the water we drink and the air we breathe, to the medicine we take, to the technologies that permeate our daily lives. When industry interests overshadow public welfare, democracy itself is at risk.

This article aims to expand Robert F. Kennedy Jr.’s arguments into a detailed exploration of the problem of regulatory capture, and how—and why—he believes he can dismantle it. We’ll investigate what “capturing” an agency looks like in practice, examine the agencies at the heart of Kennedy’s lawsuits, and discuss both the depth of the problem and potential reforms. We’ll also consider whether Kennedy’s unique legal experience really can be a blueprint for structural change, or if systemic issues go deeper than any single administration can fix.

Regulatory Capture: How It Warps Democracy

Regulatory capture occurs when a government agency, established to act in the public’s interest, instead advances the commercial or special concerns of the industries or sectors it is charged with regulating. This shift might start gradually—a few friendly lunches between regulators and industry lobbyists, a small exemption here, a defunded oversight program there. Over time, the agency’s mission quietly mutates from protecting the public to protecting industry.

Classic Signs of Regulatory Capture

Revolving Door Employment: High-level agency officials come from the industries they regulate, then return to these industries once their government service ends.
Industry-Funded Research: Agencies increasingly rely on corporate-sponsored studies rather than independent science.
Weak Enforcement: Despite having legal authority, agencies impose only minimal penalties or fail to enforce existing regulations.
Budgetary Constraints: Industries lobby to reduce the budget of regulatory agencies, crippling their ability to do independent inspections or research.
Co-Opted Rulemaking: Industry representatives gain influence in drafting the rules they will later be subject to.

When you multiply these signs across multiple agencies—EPA, FDA, CDC, FCC, USDA, NIH—the outcome is a government that often stifles real safety measures or environmental protections. Instead, we get token regulations that rarely disrupt profitable business models.

RFK Jr.’s 40-Year Odyssey: Why His Experience Matters

It’s one thing to talk about “draining the swamp,” as many politicians promise, and quite another to have decades of hands-on experience challenging major federal agencies in court. RFK Jr. is an environmental attorney who cut his teeth suing corporate polluters and the government bodies that failed to hold them accountable. Along the way, he discovered that many of these agencies were systematically compromised.

A Snapshot of Kennedy’s Journey

1980s to 1990s: Focused on environmental cases like those involving the Hudson River and major chemical companies.
Early 2000s: Lawsuits expanded to include health agencies as he noticed how regulatory capture spilled into pharmaceuticals, vaccines, and more.
Recent Decades: Sued the FCC for misleading the public about cell phone radiation, the USDA for industrial farming practices, and the CDC/FDA/NIH over a host of public health issues.

Through this legal gauntlet, Kennedy claims to have identified not just the structural flaws—like revolving-door hiring, lobbying pressures, and data manipulation—but also specific individuals and administrative “choke points” that perpetuate captured policies.

A Close Look at the Agencies: From the EPA to the FCC

Let’s examine the agencies RFK Jr. references in his video:

“I’ve sued EPA, more than any other attorney… I sued CDC, FDA, NIH… I just won a suit against the FCC… I sued the USDA…”

The EPA: Environmental Protection or Corporate Enabler?

The Environmental Protection Agency (EPA) was established in 1970 to consolidate federal research, monitoring, standard-setting, and enforcement activities related to environmental protection. Over time, though, critics argue that heavy lobbying from the oil, chemical, and mining industries has diluted the EPA’s efficacy.

Common Allegations: Downgrading or ignoring the science on pesticides, failing to enforce Clean Air or Clean Water Act violations, and slow responses to environmental disasters.
Kennedy’s Battles: Suits over mercury pollution, water contamination, and inadequate enforcement actions. He notes how corporate-friendly administrators sometimes muzzle the agency’s own scientists or create exceptions that benefit industry at the environment’s expense.

The FDA and NIH: Guardians of Health or Gatekeepers for Big Pharma?

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) play central roles in approving new drugs, medical devices, and guiding medical research. Yet they often rely on industry-funded studies, creating a climate ripe for capture.

Big Pharma Influence: Companies provide billions in “user fees” to the FDA for faster drug approvals, arguably making the FDA dependent on pharmaceutical money.
Kennedy’s Perspective: He has sued them for ignoring or downplaying adverse effects of certain drugs and vaccines. He underscores a pattern where these agencies align with industry data, sometimes to the detriment of independent research findings.

The CDC: Public Health vs. Private Interests

The Centers for Disease Control and Prevention (CDC) is tasked with controlling and preventing disease outbreaks, investigating public health threats, and offering health guidelines. But:

Funding Ties: A portion of CDC’s budget can come from private foundations or industry-linked entities, raising questions of bias.
Vaccine Policy: Critics say the CDC’s Advisory Committee on Immunization Practices is influenced by drug manufacturers, sometimes leading to inflated vaccine schedules or questionable approvals.

RFK Jr. contends that he’s discovered evidence of financial entanglements and suppressed data on vaccine safety or chemical exposure that highlight the CDC’s drift away from its core mission of objective, science-driven policymaking.

The USDA: From Protecting the Family Farm to Big Ag Dominance

The United States Department of Agriculture (USDA) was intended to nurture and protect American farmers, ensure food safety, and oversee agricultural policy. According to Kennedy, the USDA’s alliance with mega-corporations is poisoning America’s food supply. He cites:

Overuse of Pesticides and Herbicides: Lax enforcement leads to heavy use of chemicals like glyphosate.
Monopolization: Huge agribusiness firms overshadow family farms, with the USDA often turning a blind eye to antitrust concerns.
Subsidy Imbalances: Industrial-scale monoculture agribusiness receives billions, while small farms struggle to compete.

Kennedy’s lawsuits allege that USDA officials, influenced by Big Ag lobbying, systematically favor large-scale, chemical-heavy farming over more sustainable, small-scale approaches.

The FCC: Telecom’s Trojan Horse?

In the transcript, Kennedy specifically mentions the Federal Communications Commission (FCC)—and a recent lawsuit he won against them for “lying to the public about the dangers of cell phone radiation.”

Thermal vs. Non-Thermal Effects: FCC guidelines often focus on whether a device causes tissue heating, ignoring thousands of studies pointing to potential non-thermal biological effects, from DNA breaks to oxidative stress.
Revolving Door: Top FCC officials sometimes come from telecom giants like Verizon or AT&T, and then return to the private sector.
RFK Jr.’s Lawsuit: This legal victory forced the FCC to address claims that it had ignored key scientific evidence. Although the case was heralded as a win for consumer safety, critics say major telecom companies still exert enormous influence over regulatory standards.

Mechanisms of Capture: How Industries Co-Opt Their Regulators

Beyond naming these agencies, we must explore how the capturing happens. RFK Jr. alludes to “perverse incentive systems” and “individuals who need to be moved.” Let’s outline some common tactics:

Revolving Door: As mentioned, high-level officials in a regulatory agency may have previously worked for, or expect future employment from, the industry they regulate. This fosters an environment where they favor corporate interests over public welfare.
Funding Dependencies: Agencies like the FDA sometimes rely on industry fees to fund their operations, creating a conflict of interest. If the FDA’s budget depends partly on user fees from pharmaceutical companies, it’s motivated to maintain a cozy relationship with those entities.
Manipulation of Data: Corporations may fund scientific studies designed to produce favorable outcomes, which the agency then uses in its rulemaking. Independent research that conflicts with the industry narrative can be sidelined or discredited.
Legislative Loopholes: Lobbyists push for laws that limit an agency’s regulatory powers or impose time constraints on rulemaking that effectively hamper thorough investigations.
Defunding and Political Pressure: If an agency tries to take strong enforcement action, industry lobbyists can lean on friendly politicians to threaten budget cuts or departmental reorganizations, discouraging bold regulatory moves.
Social Pressure Within the Agency: Employees who speak out against captured policies risk ostracism or even job termination. Without strong whistleblower protections, the quiet bureaucratic majority might comply just to keep their positions.

Why the Public Should Care: Health, Environment, and Democracy at Stake

Regulatory capture isn’t some arcane policy matter that exists only within the halls of Washington, D.C. Its consequences resonate in our everyday lives:

Health Risks: Captured agencies can downplay or ignore evidence that certain drugs, pesticides, or radiation sources pose genuine dangers.
Environmental Damage: If the EPA looks the other way on major polluters, entire communities can suffer from contaminated water and air.
Financial Burden: Inadequate regulation can lead to costly healthcare crises, environmental cleanups, and taxpayer-funded bailouts of companies that break rules.
Erosion of Trust: When citizens see agencies consistently siding with industry, confidence in public institutions plummets, weakening democratic legitimacy.

In the transcript, RFK Jr. points out that a near-monopolistic corporate structure—“three big companies which all own each other”—exerts enormous economic and political power. Whether he’s referring to the largest asset management firms (like BlackRock, Vanguard, and State Street) or to interlocking pharmaceutical, telecom, and food giants, the net effect is the same: public watchdogs become corporate lapdogs.

RFK Jr.’s Legal Battles: Key Cases and Their Impact

Landmark Wins Against the EPA

Kennedy’s reputation as an environmental litigator stems from multiple lawsuits challenging the EPA’s enforcement of air and water pollution standards. For instance:

Riverkeeper Cases: He worked extensively to force the EPA to uphold the Clean Water Act, particularly in the Hudson River area. These cases revealed how local polluters wielded political influence to dilute enforcement.
Mercury Pollution: Kennedy joined lawsuits urging the EPA to regulate mercury emissions from power plants more rigorously, citing the neurotoxic risks to children.

While these efforts produced some victories, they also highlighted how deeply embedded the revolving door was: ex-industry personnel often wrote or enforced the very rules that set pollution limits.

Challenging Big Food: The USDA Lawsuits

RFK Jr. emphasizes the USDA’s role in facilitating “mass poisoning” through industrial-scale agriculture. Some notable points:

Subsidy Distribution: He’s been involved in exposing how Big Ag’s lobbying ensures it receives lion’s share of federal subsidies, leaving small farmers behind.
Chemical Use: Litigation often focuses on the USDA’s failure to limit toxic pesticides, which degrade soil health and compromise food quality.

Though incremental reforms have been achieved, these lawsuits expose a consistent pattern: industry-friendly leadership within the USDA rarely enforces policies that might disrupt corporate profits.

The FCC Suit: Unmasking the Dangers of Cell Phone Radiation

One of Kennedy’s most recent lawsuits targeted the FCC for allegedly misleading the public on cell phone safety:

Core Argument: The FCC’s guidelines focus primarily on whether radiofrequency (RF) radiation “cooks” human tissue. Emerging science suggests non-thermal effects—such as DNA breaks, oxidative stress, and neurological impacts—are significant, even at low exposure levels.
Court Ruling: In 2021, a U.S. Court of Appeals found the FCC had not given a satisfactory explanation for ignoring the latest research on non-thermal risks. This ruling forced the FCC to reevaluate its stance, though it remains to be seen if meaningful policy changes will ensue.

For many observers, this case is a microcosm of how regulatory capture works in high-tech sectors: massive telecom firms influence the rules that define acceptable risk, effectively sidestepping thorough scrutiny of potential health hazards.

CDC, FDA, and NIH Litigation: A Pattern of Concealment

Kennedy has also sued health agencies like the CDC, FDA, and NIH, primarily around issues of vaccine safety, pharmaceutical regulation, and data transparency. Without delving into every detail:

Sealed Documents: Lawsuits sometimes force agencies to release internal documents that reveal conflicts of interest or data suppression.
Policy Implications: The outcome of these cases can shape vaccine recommendations, drug approvals, and public confidence in health interventions.

A Blueprint for Dismantling Regulatory Capture

In the video snippet, RFK Jr. states:

“I know the perverse incentives and the built-in conflicts that need to be changed… a lot of people say they’ll drain the swamp, but they don’t know how. I know how.”

What would “knowing how” entail in real terms? Below is a potential outline, combining insights from Kennedy’s public statements and general reforms recommended by experts in regulatory ethics:

Personnel Overhaul: Removing Key “Conflict Agents”

Identify High-Level Conflicts: Root out individuals with deep industry ties who set policy, conduct scientific reviews, or allocate agency resources.
Prohibit Revolving Door: Impose mandatory waiting periods before ex-industry hires can make regulatory decisions that benefit their former employers.

Transparent Funding and Research

Independent Budgets: Agencies like the FDA should not rely so heavily on user fees from pharmaceutical companies. Funding should come primarily from Congress, reducing direct industry leverage.
Open-Source Data: Require that all research data informing policy decisions be publicly accessible, making it harder to bury unfavorable findings.

Reinforcing Ethical Boundaries

Stricter Disclosure: Officials must declare all financial interests, consultancies, and potential conflicts. Penalties for non-disclosure must be meaningful.
Peer-Reviewed Panels: Key committees—like vaccine advisory boards—should be formed transparently, with independent scientists who have minimal or no industry ties.

Whistleblower Protections

Legal Shields: Strengthen legislation so employees who reveal data suppression, fraud, or undue corporate influence are protected from retaliation.
Incentivize Truth: Provide financial rewards or career safeguards for public servants who expose misconduct.

Legislative and Executive Will

Revise Statutory Authority: Give agencies the power to enforce regulations without undue political interference. This may require legislative reform to remove “poison pills” introduced by corporate lobbyists.
Presidential Leadership: A strong executive branch that appoints reform-minded individuals to key roles can accelerate change—assuming they follow through on promises.

Widening Our Lens: Examples Beyond the U.S.

Regulatory capture is not an American anomaly. Countries around the world face similar issues:

European Union (EU): Lobbying in Brussels has shaped regulations on chemicals (e.g., REACH legislation). While stricter than the U.S. in some respects, the EU still grapples with corporate influence.
Developing Nations: In places where regulatory frameworks are weaker, major global corporations can effectively write the rules in their favor.
Global Agencies: Even the World Health Organization (WHO) has been accused of caving to Big Pharma or donor-state pressure in certain controversies.

International examples underscore that dismantling regulatory capture demands global vigilance, not just local reforms.

Critiques, Caveats, and Counterarguments

No debate is one-sided. Even as RFK Jr. calls for dismantling regulatory capture, critics voice concerns:

Personal Agendas: Some question whether Kennedy’s battles with agencies might be driven partly by personal or political motives.
Complexity of Governance: Others argue that “dismantling capture” might be unrealistic given the complexity of modern governance and the scale of corporate interests.
Need for Industry Expertise: Regulators often rely on industry know-how to make informed decisions, so the solution isn’t simply banning all cross-over hires.
Resource Constraints: Agencies sometimes face budget shortfalls or staff shortages that hamper effective oversight, irrespective of capture. Real reforms would require robust funding and modernization.

While these caveats don’t invalidate Kennedy’s points, they highlight the nuance of any large-scale regulatory overhaul.

Why “Knowing How” Is Just the First Step

Robert F. Kennedy Jr.’s statement—“I know how to dismantle it. I’ve spent 40 years suing those agencies”—resonates because it speaks directly to the frustrations many Americans feel about government ineffectiveness and corporate overreach. Through his lawsuits and investigative efforts, Kennedy argues he has witnessed the bowels of federal agencies, mapping out the individuals, incentive structures, and legislative booby traps that perpetuate a system of capture.

Yet knowing how to dismantle regulatory capture is different from actually doing it. Even if one enters a position of power—say, as head of a federal agency or an influential legislator—the swirl of entrenched interests, political compromises, and corporate lobbying can stall or dilute reform. Real change might demand a groundswell of public support, unwavering political commitment, and a cultural shift that places ethical governance above immediate commercial gains.

Still, RFK Jr.’s experiences—and his evident passion for the subject—offer valuable insights into why these agencies so often betray the public trust and how they might be reclaimed. If the public can be rallied to demand transparency, accountability, and re-empowered oversight, then perhaps the blueprint he speaks of can be transformed from words into action.

In essence, the conversation about regulatory capture is bigger than any single agency, lawsuit, or administration. It’s about the soul of democracy: ensuring that the public interest is never drowned out by the roar of corporate profiteering. And if Robert F. Kennedy Jr. can indeed deliver on his promise to “dismantle” the beast, we may yet see a renaissance of regulatory bodies acting as true guardians of public health, environmental integrity, and consumer well-being.

Source